Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014304 |
| CAS No | NA |
| Mol.F. | C28H32N2O3 |
| Mol.Wt. | 444.58 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014305 |
| CAS No | NA |
| Mol.F. | C19H18N2O |
| Mol.Wt. | 290.36 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014308 |
| CAS No | NA |
| Mol.F. | C18H16FN9O |
| Mol.Wt. | 393.39 |
| INV STATUS | In Stock |
| CAT No | SRC-N014309 |
| CAS No | NA |
| Mol.F. | C18H16FN9O |
| Mol.Wt. | 356.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014310 |
| CAS No | NA |
| Mol.F. | C24H41N3O4 |
| Mol.Wt. | 435.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014311 |
| CAS No | 3036581-82-2 |
| Mol.F. | C19H31N3O6 |
| Mol.Wt. | 397.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014312 |
| CAS No | 3035190-53-2 |
| Mol.F. | C21H23N5O3S |
| Mol.Wt. | 425.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014313 |
| CAS No | NA |
| Mol.F. | C8H13N3O2 |
| Mol.Wt. | 183.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014314 |
| CAS No | NA |
| Mol.F. | C18H19ClN4O5S |
| Mol.Wt. | 438.9 |
| INV STATUS | In Stock |
| CAT No | SRC-N014318 |
| CAS No | NA |
| Mol.F. | C12H13FN4O2 |
| Mol.Wt. | 264.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014317 |
| CAS No | NA |
| Mol.F. | C29H34N2O5 |
| Mol.Wt. | 490.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014316 |
| CAS No | NA |
| Mol.F. | C21H25N3O6 |
| Mol.Wt. | 415.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014315 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014319 |
| CAS No | 2470438-57-2 |
| Mol.F. | C9H15N3O3 |
| Mol.Wt. | 213.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014320 |
| CAS No | NA |
| Mol.F. | C9H20N2O3 |
| Mol.Wt. | 204.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014321 |
| CAS No | NA |
| Mol.F. | C14H12N8O3 |
| Mol.Wt. | 340.3 |
| INV STATUS | CUSTOM SYNTHESIS |